The Li Ka Shing Applied Virology Institute (LKSAVI) at the University of Alberta was created to help guide nascent technologies into clinical application by providing funding, technology development support and commercialization guidance. By focusing on the gap between early discoveries and commercial products, the LKSAVI aims to become a world leader in clinical development improving patient health in teh fields of immunology, oncology and microbiology. With over $60 million of investment by the provincial and federal governments, the Li Ka Sing group occupies over 4000 m2 of brand new laboratory space. It has a Biosafety Level 3 animal bio-contaminant suite, new imaging facilities, robotics to support large-scale druve and siRNA screens, biochemistry labs, medicinal chemistry labs, and access to the fastest supercomputer in Canada for computational biology applications.